Back
Halozyme Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
HALO
Halozyme Therapeutics, Inc.
Last Price:
$64.49
Seasonality Move:
3.05%
7 Day Trial
ALL ACCESS PASS
$
7
Halozyme Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Halozyme Therapeutics, Inc. has on average historically risen by 26.3% based on the past 22 years of stock performance.
-
Halozyme Therapeutics, Inc. has risen higher in 12 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Halozyme Therapeutics, Inc. Stock Undervalued?The current Halozyme Therapeutics, Inc. [HALO] share price is $64.49. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Halozyme Therapeutics, Inc. has on average historically risen by 26.3% based on the past 22 years of stock performance.
Halozyme Therapeutics, Inc. Stock Rating
Buy
53
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. overpriced?
-
Halozyme Therapeutics, Inc. has risen higher in 12 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Halozyme Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
82.22
52-Week Low:
47.50
Prediction Charts
Market Cap:
7.5B
Price in USD:
64.49
Volume:
1.5M
Beta:
1.41
Technical Analysis
SMA50:
69.87
SMA100:
69.30
SMA200:
67.31
52-Wk Change:
2.33%
Stock Predictions
-
Is Halozyme Therapeutics, Inc. stock public?Yes, Halozyme Therapeutics, Inc. is a publicly traded company.
-
What is the Halozyme Therapeutics, Inc. stock quote today?The Halozyme Therapeutics, Inc. stock price is 64.49 USD today.
-
How to buy Halozyme Therapeutics, Inc. stock online?You can buy Halozyme Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 64.34 | 64.29 | 65.77 | 64.12 |
| Mar-17 | 64.69 | 65.13 | 65.62 | 64.47 |
| Mar-18 | 64.57 | 63.65 | 64.74 | 63.30 |
| Mar-19 | 63.18 | 63.27 | 64.37 | 62.63 |
| Mar-20 | 63.25 | 63.43 | 63.78 | 62.51 |
| Mar-23 | 64.55 | 62.86 | 65.11 | 62.63 |
| Mar-24 | 62.39 | 62.04 | 62.85 | 61.49 |
| Mar-25 | 62.78 | 63.24 | 63.62 | 62.69 |
| Mar-26 | 63.05 | 63.29 | 64.00 | 62.68 |
| Mar-27 | 63.15 | 61.63 | 63.15 | 61.33 |
| Mar-30 | 61.93 | 62.13 | 62.21 | 61.50 |
| Mar-31 | 62.75 | 64.63 | 64.89 | 62.71 |
| Apr-1 | 65.14 | 65.40 | 66.00 | 64.46 |
| Apr-2 | 64.22 | 64.49 | 65.65 | 63.61 |
Halozyme Therapeutics, Inc. Earnings
Halozyme Therapeutics, Inc. Earnings Report: Per Share Halozyme Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics, Inc. Forecast Revenue Growth
Halozyme Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.03 per share, an increase this year of $1.46 per share, and an increase next year of $1.83 per share.
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.